GSK Paxil CR Ad Medicalizes “Ordinary” Anxiety, FDA Says
Executive Summary
GlaxoSmithKline Paxil CR TV ads suggest the antidepressant is appropriate for treating anxiety that does not require medication, FDA's ad division says
You may also be interested in...
GSK Posts Paxil Pediatric Data On Website; Plans U.S. Clinical Trial Register
GlaxoSmithKline's off-the-shelf response to requests for information about off-label use of Paxil in pediatric patients notes that there are studies demonstrating efficacy of paroxetine in obsessive/compulsive disorder and social anxiety disorder
Paxil Fraud Case May Spur Congressional, FDA Action – Schering Exec
Fallout from GlaxoSmithKline's handling of Paxil pediatric studies may lead to increased pressure by Congress or FDA for greater disclosure, Schering-Plough Senior VP-Global Compliance & Business Practices Brenton Saunders said
Wyeth Effexor Claim Of Superiority To SSRIs Challenged; Radio Ad Also Cited
FDA is challenging Wyeth Effexor/Effexor XR promotions that suggest the antidepressant is more effective than SSRIs